SCHEMBL22173166

SCHEMBL22173166

c1ccc(-c2ccc(-c3ccc(-c4cccc(-c5cccc(-c6ccc(-c7ccc(-c8cccc(-n9c%10ccccc%10c%10cc(-c%11ccc%12c(c%11)c%11ccccc%11n%12-c%11ccc(-c%12ccccc%12)cc%11)ccc%109)c8)cc7)cc6)c5)c4)cc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ ATM Q13315 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ TSPO P30536 3/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ KMT2A Q03164 2/20 0.40
▸ IL1R1 P14778 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ FAAH O00519 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ MGLL Q99685 1/20 0.39
▸ PTGER4 P35408 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ EDNRB P24530 1/20 0.37
▸ EDNRA P25101 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22173045 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22172918 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22172785 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22173023 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22172879 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL24677175 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22173237 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22173425 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22173037 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4
SCHEMBL22172917 1.00 L3MBTL1 (0.56) L3MBTL1ATMKDM4ETSPOHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 — — US disclosed
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 — — US disclosed
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-03 — — US disclosed
US-20200207739-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 L3MBTL1 175/4885ATM 1887/4885KDM4E 3931/4885
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 L3MBTL1 175/4885ATM 1887/4885KDM4E 3931/4885
US-20200207739-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 L3MBTL1 175/4885ATM 1887/4885KDM4E 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback